BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32554852)

  • 1. MiR-126 promotes esophageal squamous cell carcinoma via inhibition of apoptosis and autophagy.
    Li M; Meng X; Li M
    Aging (Albany NY); 2020 Jun; 12(12):12107-12118. PubMed ID: 32554852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-296-5p inhibits cell invasion and migration of esophageal squamous cell carcinoma by downregulating STAT3 signaling.
    Wang ZZ; Luo YR; Du J; Yu Y; Yang XZ; Cui YJ; Jin XF
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5206-5214. PubMed ID: 31298412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA hsa_circ_0000654 promotes esophageal squamous cell carcinoma progression by regulating the miR-149-5p/IL-6/STAT3 pathway.
    Xu Z; Tie X; Li N; Yi Z; Shen F; Zhang Y
    IUBMB Life; 2020 Mar; 72(3):426-439. PubMed ID: 31778020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma.
    Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H
    Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of miR-30a-3p/5p promotes esophageal squamous cell carcinoma cell proliferation by activating the Wnt signaling pathway.
    Qi B; Wang Y; Chen ZJ; Li XN; Qi Y; Yang Y; Cui GH; Guo HZ; Li WH; Zhao S
    World J Gastroenterol; 2017 Dec; 23(45):7965-7977. PubMed ID: 29259372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-145 Regulates the sensitivity of esophageal squamous cell carcinoma cells to 5-FU via targeting REV3L.
    Chen Q; Hou J; Wu Z; Zhao J; Ma D
    Pathol Res Pract; 2019 Jul; 215(7):152427. PubMed ID: 31072625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
    Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
    J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-214 promotes cell meastasis and inhibites apoptosis of esophageal squamous cell carcinoma via PI3K/AKT/mTOR signaling pathway.
    Guanen Q; Junjie S; Baolin W; Chaoyang W; Yajuan Y; Jing L; Junpeng L; Gaili N; Zhongping W; Jun W
    Biomed Pharmacother; 2018 Sep; 105():350-361. PubMed ID: 29864623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-messenger RNA regulatory network of esophageal squamous cell carcinoma and the identification of miR-1 as a biomarker of patient survival.
    Wei Q; Li X; Yu W; Zhao K; Qin G; Chen H; Gu Y; Ding F; Zhu Z; Fu X; Sun M
    J Cell Biochem; 2019 Aug; 120(8):12259-12272. PubMed ID: 31017699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-133a-3p suppresses cell proliferation, migration, and invasion and promotes apoptosis in esophageal squamous cell carcinoma.
    Yin Y; Du L; Li X; Zhang X; Gao Y
    J Cell Physiol; 2019 Aug; 234(8):12757-12770. PubMed ID: 30537034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal lncRNA ZFAS1 regulates esophageal squamous cell carcinoma cell proliferation, invasion, migration and apoptosis via microRNA-124/STAT3 axis.
    Li Z; Qin X; Bian W; Li Y; Shan B; Yao Z; Li S
    J Exp Clin Cancer Res; 2019 Nov; 38(1):477. PubMed ID: 31775815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of miR-519 enhances radiosensitivity of esophageal squamous cell carcinoma trough targeting PI3K/AKT/mTOR signaling pathway.
    Zhang Y; Chen W; Wang H; Pan T; Zhang Y; Li C
    Cancer Chemother Pharmacol; 2019 Dec; 84(6):1209-1218. PubMed ID: 31529206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linc-ROR regulates apoptosis in esophageal squamous cell carcinoma via modulation of p53 ubiquitination by targeting miR-204-5p/MDM2.
    Gao H; Wang T; Zhang P; Shang M; Gao Z; Yang F; Liu R
    J Cell Physiol; 2020 Mar; 235(3):2325-2335. PubMed ID: 31541467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of lncRNAXLOC_001659 inhibits proliferation and invasion of esophageal squamous cell carcinoma cells.
    Li FZ; Zang WQ
    World J Gastroenterol; 2019 Nov; 25(42):6299-6310. PubMed ID: 31754291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-874-3p is an independent prognostic factor and functions as an anti-oncomir in esophageal squamous cell carcinoma via targeting STAT3.
    Yuan RB; Zhang SH; He Y; Zhang XY; Zhang YB
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7265-7273. PubMed ID: 30468470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The miR-1224-5p/TNS4/EGFR axis inhibits tumour progression in oesophageal squamous cell carcinoma.
    Shi ZZ; Wang WJ; Chen YX; Fan ZW; Xie XF; Yang LY; Chang C; Cai Y; Hao JJ; Wang MR; Bai J
    Cell Death Dis; 2020 Jul; 11(7):597. PubMed ID: 32732965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-450a-5p inhibits autophagy and enhances radiosensitivity by targeting dual-specificity phosphatase 10 in esophageal squamous cell carcinoma.
    Chen H; Yao X; Di X; Zhang Y; Zhu H; Liu S; Chen T; Yu D; Sun X
    Cancer Lett; 2020 Jul; 483():114-126. PubMed ID: 32014456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma.
    Zuo J; Zhao M; Fan Z; Liu B; Wang Y; Li Y; Lv P; Xing L; Zhang X; Shen H
    Thorac Cancer; 2020 Mar; 11(3):738-747. PubMed ID: 32012470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-601 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma (ESCC) by targeting HDAC6.
    Liu C; Tian X; Sun HB; Wang ZF; Jiang LF; Li ZX
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1069-1076. PubMed ID: 30779074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.